25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Bio Path Holdings Inc
Buy, Hold or Sell?

Let's analyze Bio Path Holdings Inc together

I guess you are interested in Bio Path Holdings Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bio Path Holdings Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Bio Path Holdings Inc

I send you an email if I find something interesting about Bio Path Holdings Inc.

1. Quick Overview

1.1. Quick analysis of Bio Path Holdings Inc (30 sec.)










1.2. What can you expect buying and holding a share of Bio Path Holdings Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.17
Expected worth in 1 year
$-0.92
How sure are you?
22.5%

+ What do you gain per year?

Total Gains per Share
$-0.75
Return On Investment
-92.3%

For what price can you sell your share?

Current Price per Share
$0.81
Expected price per share
$0.5933 - $4.55
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Bio Path Holdings Inc (5 min.)




Live pricePrice per Share (EOD)
$0.81
Intrinsic Value Per Share
$-36.65 - $-26.52
Total Value Per Share
$-36.81 - $-26.68

2.2. Growth of Bio Path Holdings Inc (5 min.)




Is Bio Path Holdings Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$712k$7.7m-$8.1m-2,022.1%

How much money is Bio Path Holdings Inc making?

Current yearPrevious yearGrowGrow %
Making money-$2.6m-$4.1m$1.5m58.2%
Net Profit Margin-307.7%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Bio Path Holdings Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#808 / 933

Most Revenue
#681 / 933

Most Profit
#316 / 933

Most Efficient
#565 / 933
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Bio Path Holdings Inc?

Welcome investor! Bio Path Holdings Inc's management wants to use your money to grow the business. In return you get a share of Bio Path Holdings Inc.

First you should know what it really means to hold a share of Bio Path Holdings Inc. And how you can make/lose money.

Speculation

The Price per Share of Bio Path Holdings Inc is $0.814. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bio Path Holdings Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bio Path Holdings Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.17. Based on the TTM, the Book Value Change Per Share is $-0.19 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.42 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bio Path Holdings Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.49-60.3%-0.61-75.0%-0.97-118.6%-0.62-75.9%-0.52-64.1%
Usd Book Value Change Per Share-0.47-57.1%-0.19-23.1%-0.42-51.5%-0.19-23.9%-0.10-11.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.47-57.1%-0.19-23.1%-0.42-51.5%-0.19-23.9%-0.10-11.9%
Usd Price Per Share0.91-1.87-1.26-3.57-3.40-
Price to Earnings Ratio-0.46--0.79--0.32--1.88--1.91-
Price-to-Total Gains Ratio-1.96--1.63--0.56--5.04--5.46-
Price to Book Ratio-5.50--0.27-0.82-0.89-0.99-
Price-to-Total Gains Ratio-1.96--1.63--0.56--5.04--5.46-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.814
Number of shares1228
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.19-0.19
Usd Total Gains Per Share-0.19-0.19
Gains per Quarter (1228 shares)-230.74-238.59
Gains per Year (1228 shares)-922.95-954.37
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-923-9330-954-964
20-1846-18560-1909-1918
30-2769-27790-2863-2872
40-3692-37020-3817-3826
50-4615-46250-4772-4780
60-5538-55480-5726-5734
70-6461-64710-6681-6688
80-7384-73940-7635-7642
90-8307-83170-8589-8596
100-9229-92400-9544-9550

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.039.00.02.5%2.079.00.02.5%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%5.015.00.025.0%9.030.01.022.5%20.053.08.024.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.081.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%5.015.00.025.0%9.030.01.022.5%20.053.08.024.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Bio Path Holdings Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.465-0.188-60%-0.419-10%-0.194-58%-0.097-79%
Book Value Per Share---0.165-0.093-44%1.791-109%2.597-106%2.441-107%
Current Ratio--0.8591.138-25%5.713-85%11.713-93%12.043-93%
Debt To Asset Ratio--1.2401.334-7%0.254+388%0.363+242%0.250+395%
Debt To Equity Ratio---2.316-100%0.407-100%0.594-100%0.391-100%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--803839.2115850774.020-86%9222948.625-91%30788843.989-97%26098453.942-97%
Eps---0.491-0.610+24%-0.965+97%-0.618+26%-0.522+6%
Ev To Ebitda Ratio---0.076-0.439+475%-0.538+604%-2.967+3780%-2.994+3815%
Ev To Sales Ratio--infinfnan%infnan%infnan%infnan%
Free Cash Flow Per Share---0.796-0.552-31%-0.855+7%-0.580-27%-0.496-38%
Free Cash Flow To Equity Per Share---0.800-0.104-87%-0.656-18%0.174-559%0.217-468%
Gross Profit Margin--1.0001.008-1%1.0000%1.0020%1.0010%
Intrinsic Value_10Y_max---26.517--------
Intrinsic Value_10Y_min---36.645--------
Intrinsic Value_1Y_max---2.083--------
Intrinsic Value_1Y_min---2.705--------
Intrinsic Value_3Y_max---6.696--------
Intrinsic Value_3Y_min---9.014--------
Intrinsic Value_5Y_max---11.837--------
Intrinsic Value_5Y_min---16.244--------
Market Cap3505808.460-12%3918839.2118067774.020-51%5437448.625-28%19449293.989-80%16684882.717-77%
Net Profit Margin----3.0770%-0%-0.6150%-6.6360%
Operating Margin----2.7670%-0%-0.5530%-13.8870%
Operating Ratio---2.805-100%-0%0.561-100%18.582-100%
Pb Ratio-4.924+11%-5.504-0.267-95%0.817-774%0.889-719%0.990-656%
Pe Ratio-0.414+11%-0.463-0.792+71%-0.319-31%-1.879+306%-1.906+311%
Price Per Share0.814-12%0.9101.873-51%1.263-28%3.566-74%3.399-73%
Price To Free Cash Flow Ratio-0.256+11%-0.286-1.375+381%-0.365+28%-1.988+596%-1.925+573%
Price To Total Gains Ratio-1.750+11%-1.956-1.625-17%-0.558-71%-5.044+158%-5.455+179%
Quick Ratio--0.1670.460-64%3.459-95%10.372-98%10.669-98%
Return On Assets---0.713-0.978+37%-0.502-30%-0.374-48%-0.301-58%
Return On Equity----2.2730%-0.7400%-0.6880%-0.4930%
Total Gains Per Share---0.465-0.188-60%-0.419-10%-0.194-58%-0.097-79%
Usd Book Value---712000.000-401250.000-44%7712250.000-109%14324550.000-105%12082308.400-106%
Usd Book Value Change Per Share---0.465-0.188-60%-0.419-10%-0.194-58%-0.097-79%
Usd Book Value Per Share---0.165-0.093-44%1.791-109%2.597-106%2.441-107%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--803839.2115850774.020-86%9222948.625-91%30788843.989-97%26098453.942-97%
Usd Eps---0.491-0.610+24%-0.965+97%-0.618+26%-0.522+6%
Usd Free Cash Flow---3428000.000-2377000.000-31%-3680250.000+7%-2877250.000-16%-2324115.500-32%
Usd Free Cash Flow Per Share---0.796-0.552-31%-0.855+7%-0.580-27%-0.496-38%
Usd Free Cash Flow To Equity Per Share---0.800-0.104-87%-0.656-18%0.174-559%0.217-468%
Usd Market Cap3505808.460-12%3918839.2118067774.020-51%5437448.625-28%19449293.989-80%16684882.717-77%
Usd Price Per Share0.814-12%0.9101.873-51%1.263-28%3.566-74%3.399-73%
Usd Profit---2115000.000-2628250.000+24%-4158250.000+97%-3037300.000+44%-2415691.950+14%
Usd Revenue---68500.000-100%-0%13700.000-100%9350.000-100%
Usd Total Gains Per Share---0.465-0.188-60%-0.419-10%-0.194-58%-0.097-79%
 EOD+2 -6MRQTTM+10 -24YOY+11 -205Y+9 -2510Y+9 -25

3.3 Fundamental Score

Let's check the fundamental score of Bio Path Holdings Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.414
Price to Book Ratio (EOD)Between0-1-4.924
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.167
Current Ratio (MRQ)Greater than10.859
Debt to Asset Ratio (MRQ)Less than11.240
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.713
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Bio Path Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.242
Ma 20Greater thanMa 501.046
Ma 50Greater thanMa 1000.890
Ma 100Greater thanMa 2000.951
OpenGreater thanClose0.857
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Bio Path Holdings Inc

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing BP1001-A that is in Phase I clinical trial for the treatment of solid tumors; Liposomal Bcl-2 (BP1002), which is in Phase I clinical trial for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; and Liposomal STAT3 (BP1003) for treating pancreatic cancer, non-small cell lung cancer, and AML. The company was founded in 2007 and is based in Bellaire, Texas.

Fundamental data was last updated by Penke on 2025-01-16 14:49:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Bio Path Holdings Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Bio Path Holdings Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bio Path Holdings Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-307.7%+307.7%
TTM-307.7%YOY--307.7%
TTM-307.7%5Y-61.5%-246.1%
5Y-61.5%10Y-663.6%+602.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--104.6%+104.6%
TTM-307.7%-216.4%-91.3%
YOY--208.6%+208.6%
5Y-61.5%-353.9%+292.4%
10Y-663.6%-488.0%-175.6%
4.3.1.2. Return on Assets

Shows how efficient Bio Path Holdings Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bio Path Holdings Inc to the Biotechnology industry mean.
  • -71.3% Return on Assets means that Bio Path Holdings Inc generated $-0.71 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bio Path Holdings Inc:

  • The MRQ is -71.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -97.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-71.3%TTM-97.8%+26.5%
TTM-97.8%YOY-50.2%-47.6%
TTM-97.8%5Y-37.4%-60.3%
5Y-37.4%10Y-30.1%-7.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-71.3%-12.7%-58.6%
TTM-97.8%-13.0%-84.8%
YOY-50.2%-12.3%-37.9%
5Y-37.4%-13.7%-23.7%
10Y-30.1%-15.7%-14.4%
4.3.1.3. Return on Equity

Shows how efficient Bio Path Holdings Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bio Path Holdings Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Bio Path Holdings Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bio Path Holdings Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-227.3%+227.3%
TTM-227.3%YOY-74.0%-153.3%
TTM-227.3%5Y-68.8%-158.5%
5Y-68.8%10Y-49.3%-19.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.8%+16.8%
TTM-227.3%-17.8%-209.5%
YOY-74.0%-16.4%-57.6%
5Y-68.8%-20.6%-48.2%
10Y-49.3%-21.2%-28.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Bio Path Holdings Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Bio Path Holdings Inc is operating .

  • Measures how much profit Bio Path Holdings Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bio Path Holdings Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bio Path Holdings Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-276.7%+276.7%
TTM-276.7%YOY--276.7%
TTM-276.7%5Y-55.3%-221.4%
5Y-55.3%10Y-1,388.7%+1,333.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--193.6%+193.6%
TTM-276.7%-321.1%+44.4%
YOY--227.9%+227.9%
5Y-55.3%-373.0%+317.7%
10Y-1,388.7%-506.1%-882.6%
4.3.2.2. Operating Ratio

Measures how efficient Bio Path Holdings Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bio Path Holdings Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.805-2.805
TTM2.805YOY-+2.805
TTM2.8055Y0.561+2.244
5Y0.56110Y18.582-18.021
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.171-2.171
TTM2.8053.250-0.445
YOY-3.231-3.231
5Y0.5614.838-4.277
10Y18.5826.440+12.142
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Bio Path Holdings Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Bio Path Holdings Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.86 means the company has $0.86 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bio Path Holdings Inc:

  • The MRQ is 0.859. The company is just not able to pay all its short-term debts. -1
  • The TTM is 1.138. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ0.859TTM1.138-0.279
TTM1.138YOY5.713-4.575
TTM1.1385Y11.713-10.575
5Y11.71310Y12.043-0.330
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8593.610-2.751
TTM1.1383.850-2.712
YOY5.7134.605+1.108
5Y11.7135.895+5.818
10Y12.0436.178+5.865
4.4.3.2. Quick Ratio

Measures if Bio Path Holdings Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bio Path Holdings Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.17 means the company can pay off $0.17 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bio Path Holdings Inc:

  • The MRQ is 0.167. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.460. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.167TTM0.460-0.294
TTM0.460YOY3.459-2.998
TTM0.4605Y10.372-9.911
5Y10.37210Y10.669-0.297
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1673.034-2.867
TTM0.4603.355-2.895
YOY3.4594.297-0.838
5Y10.3725.890+4.482
10Y10.6696.434+4.235
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Bio Path Holdings Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Bio Path Holdings Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bio Path Holdings Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.24 means that Bio Path Holdings Inc assets are financed with 124.0% credit (debt) and the remaining percentage (100% - 124.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bio Path Holdings Inc:

  • The MRQ is 1.240. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.334. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.240TTM1.334-0.094
TTM1.334YOY0.254+1.080
TTM1.3345Y0.363+0.971
5Y0.36310Y0.250+0.112
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2400.341+0.899
TTM1.3340.343+0.991
YOY0.2540.310-0.056
5Y0.3630.366-0.003
10Y0.2500.385-0.135
4.5.4.2. Debt to Equity Ratio

Measures if Bio Path Holdings Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bio Path Holdings Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bio Path Holdings Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.316-2.316
TTM2.316YOY0.407+1.909
TTM2.3165Y0.594+1.722
5Y0.59410Y0.391+0.203
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.393-0.393
TTM2.3160.429+1.887
YOY0.4070.382+0.025
5Y0.5940.439+0.155
10Y0.3910.489-0.098
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Bio Path Holdings Inc generates.

  • Above 15 is considered overpriced but always compare Bio Path Holdings Inc to the Biotechnology industry mean.
  • A PE ratio of -0.46 means the investor is paying $-0.46 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bio Path Holdings Inc:

  • The EOD is -0.414. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.463. Based on the earnings, the company is expensive. -2
  • The TTM is -0.792. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.414MRQ-0.463+0.049
MRQ-0.463TTM-0.792+0.329
TTM-0.792YOY-0.319-0.474
TTM-0.7925Y-1.879+1.086
5Y-1.87910Y-1.906+0.027
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.414-2.247+1.833
MRQ-0.463-2.693+2.230
TTM-0.792-3.214+2.422
YOY-0.319-3.335+3.016
5Y-1.879-6.368+4.489
10Y-1.906-6.692+4.786
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bio Path Holdings Inc:

  • The EOD is -0.256. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.286. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.375. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.256MRQ-0.286+0.030
MRQ-0.286TTM-1.375+1.090
TTM-1.375YOY-0.365-1.010
TTM-1.3755Y-1.988+0.613
5Y-1.98810Y-1.925-0.064
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.256-2.993+2.737
MRQ-0.286-3.671+3.385
TTM-1.375-4.037+2.662
YOY-0.365-4.482+4.117
5Y-1.988-8.190+6.202
10Y-1.925-9.383+7.458
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Bio Path Holdings Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -5.50 means the investor is paying $-5.50 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bio Path Holdings Inc:

  • The EOD is -4.924. Based on the equity, the company is expensive. -2
  • The MRQ is -5.504. Based on the equity, the company is expensive. -2
  • The TTM is -0.267. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.924MRQ-5.504+0.580
MRQ-5.504TTM-0.267-5.237
TTM-0.267YOY0.817-1.084
TTM-0.2675Y0.889-1.157
5Y0.88910Y0.990-0.101
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.9241.933-6.857
MRQ-5.5042.265-7.769
TTM-0.2672.447-2.714
YOY0.8172.454-1.637
5Y0.8893.664-2.775
10Y0.9904.239-3.249
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Bio Path Holdings Inc.

4.8.1. Institutions holding Bio Path Holdings Inc

Institutions are holding 1.085% of the shares of Bio Path Holdings Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Geode Capital Management, LLC0.3157013598273225.1426
2024-09-30Vanguard Group Inc0.313501350200
2024-09-30Virtu Financial LLC0.28620.000612325123250
2024-09-30Citadel Advisors Llc0.2535010917109170
2024-09-30Tower Research Capital LLC0.07830.00013371-362-9.6973
2024-09-30UBS Group AG0.0663028561997232.4796
2024-09-30BlackRock Inc0.05530238100
2024-09-30Morgan Stanley - Brokerage Accounts0.0008035-35-50
2024-09-30Bank of America Corp0.0006027-19-41.3043
2024-09-30Group One Trading, LP0.000502100
2024-09-30Global Retirement Partners, LLC.0.00010400
2024-09-30Hanson Mcclain Inc00100
2024-06-30Wells Fargo & Co000-5-100
2024-09-30Qube Research & Technologies000-100-100
2024-09-30Armistice Capital, LLC000-97000-100
2024-09-30HRT FINANCIAL LLC000-14085-100
Total 1.37080.000759038-83635-141.7%

4.9.2. Funds holding Bio Path Holdings Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-11-30Vanguard Institutional Extnd Mkt Idx Tr0.313501350200
2024-11-30Fidelity Extended Market Index0.277801196300
2024-09-30NT Ext Equity Mkt Idx Fd - NL0.0128055000
2024-11-30Fidelity Series Total Market Index0.0113048500
2024-09-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.0103044310.2262
2024-09-30Northern Trust Extended Eq Market Idx0.0071030500
2024-09-30NT Ext Equity Mkt Idx Fd - L0.0071030500
2024-11-30Spartan Extended Market Index Pool E0.0052022500
2024-11-30Fidelity Total Market Index0.0039017000
2024-09-30NT Ext Eq Mkt Indx Fd DC Lending Tier 50.001104700
2024-12-31State St US Ttl Mkt Indx SL Cl I0.00104500
2024-09-30Northern Trust Wilshire 50000.000301300
2024-09-30BNYM Mellon SL Market Completion UC10.000301200
2024-12-31State St US Extended Mkt Indx NL Cl C0.00020900
2024-06-30SSgA U.S. Total Market Index Strategy0.000104133.3333
2024-09-30BNYM Mellon NSL Mkt Completion Fund Inst00200
2024-06-30Blackstone Alternative Multi-Strategy I00100
Total 0.652028081+2+0.0%

5.3. Insider Transactions

Insiders are holding 0.04% of the shares of Bio Path Holdings Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2019-01-18Armistice Capital Master FundSELL644572.66
2015-07-13Michael J GarrisonBUY73431.22
2015-07-09Michael J GarrisonBUY87241.17
2015-07-08Michael J GarrisonBUY600001.19
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets2,965
Total Liabilities3,677
Total Stockholder Equity-712
 As reported
Total Liabilities 3,677
Total Stockholder Equity+ -712
Total Assets = 2,965

Assets

Total Assets2,965
Total Current Assets2,899
Long-term Assets66
Total Current Assets
Cash And Cash Equivalents 562
Other Current Assets 2,337
Total Current Assets  (as reported)2,899
Total Current Assets  (calculated)2,899
+/-0
Long-term Assets
Property Plant Equipment 66
Long-term Assets  (as reported)66
Long-term Assets  (calculated)66
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,375
Long-term Liabilities302
Total Stockholder Equity-712
Total Current Liabilities
Short-term Debt 26
Accounts payable 1,036
Other Current Liabilities 2,313
Total Current Liabilities  (as reported)3,375
Total Current Liabilities  (calculated)3,375
+/-0
Long-term Liabilities
Capital Lease Obligations 26
Long-term Liabilities  (as reported)302
Long-term Liabilities  (calculated)26
+/- 276
Total Stockholder Equity
Common Stock4
Retained Earnings -114,748
Other Stockholders Equity 114,032
Total Stockholder Equity (as reported)-712
Total Stockholder Equity (calculated)-712
+/-0
Other
Capital Stock4
Cash and Short Term Investments 562
Common Stock Shares Outstanding 3,017
Liabilities and Stockholders Equity 2,965
Net Debt -536
Net Invested Capital -712
Net Working Capital -476
Property Plant and Equipment Gross 1,144
Short Long Term Debt Total 26



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-30
> Total Assets 
0
0
0
142
142
143
145
145
131
117
70
49
117
59
5,018
4,767
4,540
4,387
4,387
3,602
3,354
3,682
3,604
3,741
3,208
3,109
3,262
3,664
3,404
3,231
2,708
2,165
2,070
2,344
2,344
3,745
5,751
5,079
18,598
17,365
16,285
15,478
14,249
13,293
11,673
10,755
8,946
7,140
13,442
12,196
10,111
9,431
7,316
8,858
8,858
5,742
3,945
2,335
21,319
19,319
17,595
22,660
19,826
17,520
14,873
16,475
33,099
31,127
30,680
26,568
24,078
21,009
18,539
15,971
11,102
6,524
5,021
3,220
1,768
5,118
2,965
2,9655,1181,7683,2205,0216,52411,10215,97118,53921,00924,07826,56830,68031,12733,09916,47514,87317,52019,82622,66017,59519,31921,3192,3353,9455,7428,8588,8587,3169,43110,11112,19613,4427,1408,94610,75511,67313,29314,24915,47816,28517,36518,5985,0795,7513,7452,3442,3442,0702,1652,7083,2313,4043,6643,2623,1093,2083,7413,6043,6823,3543,6024,3874,3874,5404,7675,018591174970117131145145143142142000
   > Total Current Assets 
0
0
0
44
44
35
37
37
35
21
66
45
22
55
2,534
2,325
2,116
1,883
1,883
1,163
951
1,250
1,195
1,313
747
644
817
1,267
1,035
1,154
654
504
458
772
772
2,253
4,299
3,667
17,226
16,034
14,927
14,114
12,935
12,029
10,460
9,593
7,834
6,079
12,407
10,653
8,350
7,785
5,787
7,435
7,435
4,514
2,824
1,929
20,866
18,605
16,886
21,990
19,193
16,924
14,315
15,956
32,618
30,639
30,233
26,140
23,610
20,563
18,137
15,615
10,791
6,259
4,802
3,042
1,637
5,019
2,899
2,8995,0191,6373,0424,8026,25910,79115,61518,13720,56323,61026,14030,23330,63932,61815,95614,31516,92419,19321,99016,88618,60520,8661,9292,8244,5147,4357,4355,7877,7858,35010,65312,4076,0797,8349,59310,46012,02912,93514,11414,92716,03417,2263,6674,2992,2537727724585046541,1541,0351,2678176447471,3131,1951,2509511,1631,8831,8832,1162,3252,5345522456621353737354444000
       Cash And Cash Equivalents 
0
0
0
5
5
12
15
15
10
5
54
33
10
17
2,506
2,253
1,775
1,507
1,507
516
266
567
455
602
106
239
766
1,222
983
952
577
162
333
534
534
1,927
4,101
3,552
16,820
15,721
14,637
13,859
12,454
11,080
9,855
8,855
6,473
4,224
11,299
9,375
7,111
6,182
4,623
5,965
5,965
2,578
2,286
1,004
19,276
17,106
15,382
20,426
17,891
14,411
12,058
13,755
30,793
28,093
26,601
23,774
21,248
17,024
13,650
10,384
6,731
3,444
2,352
1,052
188
4,006
562
5624,0061881,0522,3523,4446,73110,38413,65017,02421,24823,77426,60128,09330,79313,75512,05814,41117,89120,42615,38217,10619,2761,0042,2862,5785,9655,9654,6236,1827,1119,37511,2994,2246,4738,8559,85511,08012,45413,85914,63715,72116,8203,5524,1011,9275345343331625779529831,2227662391066024555672665161,5071,5071,7752,2532,5061710335451015151255000
       Net Receivables 
0
0
0
11
11
0
0
12
12
12
12
0
12
12
0
0
0
0
0
0
0
0
0
0
0
244
244
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
775
0
0
0
0
974
1,534
2,111
-1
951
3,545
-2
-4
-2
-1
-1
0
-632
-274
0
0-274-6320-1-1-2-4-23,545951-12,1111,53497400007750000000000000000000000000000000000244244000000000001212012121212001111000
       Other Current Assets 
0
0
0
1
1
1
0
0
1
0
0
0
1
38
29
72
341
83
83
56
77
74
132
103
110
73
51
45
52
48
56
46
45
43
43
46
50
64
157
172
194
100
123
254
201
179
750
1,276
912
902
862
1,011
511
1,470
353
604
281
593
1,163
845
1,504
788
538
2,513
1,277
2,201
850
1,010
1,519
2,366
1,410
-8
4,487
5,231
4,060
2,815
2,450
1,990
1,449
1,013
2,337
2,3371,0131,4491,9902,4502,8154,0605,2314,487-81,4102,3661,5191,0108502,2011,2772,5135387881,5048451,1635932816043531,4705111,0118629029121,2767501792012541231001941721576450464343454656485245517311010313274775683833417229381000100111000
   > Long-term Assets 
0
0
0
98
98
108
108
108
96
96
0
0
95
4
2,484
2,441
2,423
2,505
2,505
2,439
2,403
2,432
2,409
2,428
2,461
2,464
2,445
2,397
2,369
2,077
2,054
1,661
1,612
3,144
1,572
1,492
1,452
1,412
1,371
1,331
1,357
1,364
1,314
1,263
1,213
1,162
1,112
1,061
1,035
1,543
1,761
1,646
1,529
1,423
1,423
1,228
1,121
406
453
714
709
670
633
596
558
519
481
488
447
428
468
446
402
356
311
265
219
178
131
99
66
66991311782192653113564024464684284474884815195585966336707097144534061,1211,2281,4231,4231,5291,6461,7611,5431,0351,0611,1121,1621,2131,2631,3141,3641,3571,3311,3711,4121,4521,4921,5723,1441,6121,6612,0542,0772,3692,3972,4452,4642,4612,4282,4092,4322,4032,4392,5052,5052,4232,4412,4844950096961081081089898000
       Property Plant Equipment 
0
0
0
94
94
93
93
93
92
92
0
0
91
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
66
113
103
93
82
72
62
51
66
614
872
797
720
654
654
539
473
406
453
714
709
670
633
596
558
519
481
488
447
428
468
446
402
356
311
265
219
178
131
99
66
669913117821926531135640244646842844748848151955859663367070971445340647353965465472079787261466516272829310311366000000000000000000000000000910092929393939494000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,484
2,441
2,423
2,505
2,505
2,439
2,403
2,432
2,409
2,428
2,461
2,464
2,445
2,397
2,369
2,077
2,054
1,661
1,612
1,572
1,572
1,492
1,452
1,412
1,371
1,331
1,291
1,251
1,211
1,171
1,130
1,090
1,050
1,010
969
929
889
849
809
769
769
689
648
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000006486897697698098498899299691,0101,0501,0901,1301,1711,2111,2511,2911,3311,3711,4121,4521,4921,5721,5721,6121,6612,0542,0772,3692,3972,4452,4642,4612,4282,4092,4322,4032,4392,5052,5052,4232,4412,48400000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,054
1,661
1,612
1,572
1,532
1,492
1,452
1,412
0
1,331
0
0
1,211
1,171
1,131
1,090
1,050
1,010
969
929
889
849
809
769
729
689
648
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000006486897297698098498899299691,0101,0501,0901,1311,1711,211001,33101,4121,4521,4921,5321,5721,6121,6612,054000000000000000000000000000000
> Total Liabilities 
0
0
0
319
319
140
162
162
232
251
193
190
284
328
15
7
2
327
327
230
247
265
336
413
72
247
188
221
205
316
247
243
269
329
329
268
174
295
420
334
283
562
616
692
481
937
900
813
4,065
3,956
2,019
576
767
791
791
1,005
957
1,117
1,176
1,406
1,571
1,574
1,894
1,509
1,687
1,405
1,726
1,373
1,334
1,111
1,763
1,489
2,342
1,797
1,995
1,481
2,496
2,779
4,393
3,827
3,677
3,6773,8274,3932,7792,4961,4811,9951,7972,3421,4891,7631,1111,3341,3731,7261,4051,6871,5091,8941,5741,5711,4061,1761,1179571,0057917917675762,0193,9564,065813900937481692616562283334420295174268329329269243247316205221188247724133362652472303273272715328284190193251232162162140319319000
   > Total Current Liabilities 
0
0
0
319
319
60
82
82
153
173
193
190
206
328
15
7
2
327
327
230
247
265
336
413
72
247
188
221
205
316
247
243
269
329
329
268
174
295
420
334
283
562
616
692
481
937
900
813
866
1,050
709
576
767
791
791
1,005
957
1,117
1,117
1,033
1,219
1,244
1,587
1,225
1,427
1,169
1,515
1,183
1,162
958
1,568
1,321
2,201
1,684
1,910
1,426
1,357
1,906
3,812
3,010
3,375
3,3753,0103,8121,9061,3571,4261,9101,6842,2011,3211,5689581,1621,1831,5151,1691,4271,2251,5871,2441,2191,0331,1171,1179571,0057917917675767091,050866813900937481692616562283334420295174268329329269243247316205221188247724133362652472303273272715328206190193173153828260319319000
       Short-term Debt 
0
0
0
245
245
32
54
54
55
64
82
61
90
48
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54
34
79
85
87
89
92
94
96
94
88
82
101
102
105
108
110
113
116
206
82
110
26
261108220611611311010810510210182889496949289878579345400000000000000000000000000000000000000000000489061826455545432245245000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000540000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
33
33
9
21
0
34
47
0
0
52
31
1
1
0
186
186
2
5
6
0
124
9
88
26
24
43
190
58
54
65
329
66
176
44
76
238
79
89
41
77
385
127
55
201
123
118
69
89
96
121
791
52
137
451
813
607
444
522
486
818
726
614
100
394
507
417
106
409
611
1,046
667
827
638
277
457
1,746
766
1,036
1,0367661,7464572776388276671,0466114091064175073941006147268184865224446078134511375279112196896911812320155127385774189792387644176663296554581904324268891240652186186011315200473402193333000
       Other Current Liabilities 
0
0
0
42
1
1
1
0
1
62
0
0
0
249
14
6
2
141
141
228
242
258
336
289
63
158
162
197
162
127
188
189
203
264
264
92
130
219
182
255
195
521
540
307
354
883
699
690
748
969
608
468
634
739
739
868
506
304
54
555
618
673
682
410
721
975
1,025
582
657
770
1,058
608
1,050
909
973
675
687
1,243
1,984
2,134
2,313
2,3132,1341,9841,2436876759739091,0506081,0587706575821,0259757214106826736185555430450686873973963446860896974869069988335430754052119525518221913092264264203189188127162197162158632893362582422281411412614249000621011142000
   > Long-term Liabilities 
0
0
0
0
277
80
80
80
79
78
0
0
77
79
1
1
0
0
186
2
5
6
0
124
9
88
26
24
43
190
58
54
65
0
66
176
44
76
238
79
89
41
77
385
127
55
201
123
3,199
2,906
1,310
108
133
0
52
137
451
813
59
373
352
330
307
284
260
236
211
190
172
153
195
168
141
113
85
55
1,139
873
581
817
302
3028175818731,1395585113141168195153172190211236260284307330352373598134511375201331081,3102,9063,199123201551273857741897923876441766606554581904324268891240652186001179770078798080802770000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,199
2,906
1,310
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000001,3102,9063,199000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,199
2,906
1,310
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000001,3102,9063,199000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
-177
-177
3
-17
0
-100
-134
0
0
-166
-269
5,003
4,759
4,538
4,060
4,060
3,372
3,107
3,417
3,269
3,328
3,136
2,862
3,074
3,443
3,199
2,915
2,462
1,922
1,801
2,015
2,015
3,477
5,577
4,784
18,178
17,032
16,001
14,916
13,633
12,600
11,191
9,818
8,046
6,327
9,377
8,240
8,092
8,855
6,549
8,067
8,067
4,737
2,988
1,218
20,143
17,913
16,024
21,086
17,932
16,011
13,186
15,070
31,373
29,754
29,346
25,457
22,315
19,520
16,197
14,174
9,107
5,043
2,525
441
-2,625
1,291
-712
-7121,291-2,6254412,5255,0439,10714,17416,19719,52022,31525,45729,34629,75431,37315,07013,18616,01117,93221,08616,02417,91320,1431,2182,9884,7378,0678,0676,5498,8558,0928,2409,3776,3278,0469,81811,19112,60013,63314,91616,00117,03218,1784,7845,5773,4772,0152,0151,8011,9222,4622,9153,1993,4433,0742,8623,1363,3283,2693,4173,1073,3724,0604,0604,5384,7595,003-269-16600-134-1000-173-177-177000
   Common Stock
0
0
0
0
0
1,774
1,880
0
415
0
0
0
2,736
0
42
42
42
0
42
43
43
43
47
49
49
49
49
56
56
58
58
59
59
62
62
75
75
84
89
89
89
90
90
90
90
90
90
90
96
96
96
100
100
11
11
11
13
1
3
3
3
4
4
4
4
5
7
7
7
7
7
7
7
8
8
8
11
1
1
2
4
421111888777777754444333113111111100100969696909090909090908989898475756262595958585656494949494743434342042424202,73600041501,8801,77400000
   Retained Earnings Total Equity0000000000000-71,476-69,668-67,221-64,671-61,703-59,663-56,339-53,950-51,708-49,252-47,740-45,831-42,750-41,073-39,157-36,990-34,516-32,531-32,134-30,763-29,193-27,251-25,384-23,925-22,417-21,292-19,917-18,319-17,171-15,902-15,397-14,608-13,215-12,787-12,131-11,699-10,859-10,071-9,549-8,745-8,241000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
-14
-14
-1,793
-16
-16
-16
-17
-2
0
-18
110
0
0
0
0
0
0
-4,671
0
-5,595
0
0
0
0
0
0
0
0
0
0
0
1
0
3
0
0
0
0
0
-21
0
-41
-51
-61
0
0
-94
-127
-202
-279
-330
-330
-462
0
-592
0
-691
-708
0
-744
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000-7440-708-6910-5920-462-330-330-279-202-127-9400-61-51-410-210000030100000000000-5,5950-4,671000000110-180-2-17-16-16-16-1,793-14-14000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,628
11,888
12,405
12,474
12,722
13,442
14,084
14,405
16,616
20,109
20,097
33,991
34,113
34,231
34,743
34,835
34,928
35,027
35,112
35,207
35,430
40,044
40,278
40,527
43,271
43,439
47,213
47,337
47,476
48,806
48,957
69,392
69,618
69,971
77,421
77,591
77,710
77,853
82,286
101,034
101,223
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000101,223101,03482,28677,85377,71077,59177,42169,97169,61869,39248,95748,80647,47647,33747,21343,43943,27140,52740,27840,04435,43035,20735,11235,02734,92834,83534,74334,23134,11333,99120,09720,10916,61614,40514,08413,44212,72212,47412,40511,88811,628000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
191
177
416
-1,460
0
420
437
0
0
-2,316
433
5,469
5,721
5,739
7,194
7,152
7,593
7,736
8,478
8,817
9,301
9,610
9,998
10,802
11,628
11,888
12,405
12,474
12,722
13,442
0
14,084
16,616
20,106
20,097
33,991
34,113
34,231
34,743
34,835
34,928
35,027
35,112
35,207
35,430
40,044
40,278
40,527
43,271
43,439
0
47,213
47,476
48,806
48,957
69,392
69,618
69,971
77,421
77,591
77,710
77,853
82,286
101,034
101,223
102,884
103,111
103,328
103,541
103,753
105,695
105,901
106,071
106,749
108,047
108,138
113,922
114,032
114,032113,922108,138108,047106,749106,071105,901105,695103,753103,541103,328103,111102,884101,223101,03482,28677,85377,71077,59177,42169,97169,61869,39248,95748,80647,47647,213043,43943,27140,52740,27840,04435,43035,20735,11235,02734,92834,83534,74334,23134,11333,99120,09720,10616,61614,084013,44212,72212,47412,40511,88811,62810,8029,9989,6109,3018,8178,4787,7367,5937,1527,1945,7395,7215,469433-2,316004374200-1,460416177191000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.